Anna Mercanti

506 citations
14 papers · 359 indexed · h-index 7
Topics
Breast Cancer Treatment Studies (4 papers)Cancer Treatment and Pharmacology (3 papers)Lung Cancer Treatments and Mutations (3 papers)
Partner nations
ItalyUnited StatesPoland

In The Last Decade

Anna Mercanti

13 papers receiving 345 citations

Peers

Anna Mercanti
Comparison fields: 5 of 58
  • Oncology 159
  • Surgery 117
  • Genetics 99
  • Cancer Research 92
  • Molecular Biology 78
Replace Ryszard Waśko with:
Ryszard Waśko Poland
Mari C. Vázquez‐Borrego Spain
Nicoleta Cristina Olarescu Norway
Martin Rønn Madsen Denmark
Fengming Zhu China
Soohyun P. Kim United States
Thomas R. Flint United Kingdom
K-U Eckardt Germany
Matthew J. Horne United States
Guan-Qi Gao China
Anna Mercanti relative to Ryszard Waśko Poland Ryszard Waśko's profile →
Citations per field
00.5×5.2×
Ryszard Waśko · 1×
Citations per year

Countries citing papers authored by Anna Mercanti

Since Specialization
Citations

This map shows the geographic impact of Anna Mercanti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Mercanti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Mercanti more than expected).

Fields of papers citing papers by Anna Mercanti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Mercanti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Mercanti. The network helps show where Anna Mercanti may publish in the future.

Co-authorship network of co-authors of Anna Mercanti

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Mercanti. A scholar is included among the top collaborators of Anna Mercanti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Mercanti. Anna Mercanti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 0
2 3
3 3
4 30
5 6
6 123
7 7
8 29
9 94
10 9
11 49
12 3
13 1
14 2

About Anna Mercanti

Anna Mercanti is a scholar working on Cancer Research, Endocrine and Autonomic Systems and Oncology, having authored 14 papers that have together received 359 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (4 papers), Cancer Treatment and Pharmacology (3 papers) and Lung Cancer Treatments and Mutations (3 papers). The work is most often cited by research in Genetics (99 citations), Endocrine and Autonomic Systems (58 citations) and Cancer Research (92 citations). Anna Mercanti has collaborated with scholars based in Italy, United States and Poland. Frequent co-authors include Rocco Micciolo, Elena Fiorio, Mirco Galiè, Gino Rigotti, Alessandra Marchi, Eva Surmacz, G. Baroni, Andrea Sbarbati, A. Auriemma and Marianna Terrasi. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology and International Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026